Showing results (141-150 of 503) with videos related to

Sort By:
Pageof 51
Immunotherapy|October 18, 2023
Infectious adverse events in patients with atopic dermatitis treated with baricitinibFlaminia Antonelli, Dalma Malvaso, Giacomo Caldarola, et al.
European Journal of Dermatology : EJD|February 2, 2022
Merkel cell carcinoma: an updated overview of clinico-pathological aspects, molecular genetics and therapyEmi Dika, Cristina Pellegrini, Martina Lambertini, et al.
Dermatology and Therapy|October 8, 2025
Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative ReviewMaria Esposito, Alessandro Giunta, Andrea De Berardinis, et al.
Journal of Personalized Medicine|June 25, 2025
Advanced Basal Cell Carcinoma: A Narrative Review on Current Systemic Treatments and the Neoadjuvant ApproachAndrea Paradisi, Maria Mannino, Francesco Brunetti, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2022
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitisLaura Calabrese, Andrea Chiricozzi, Clara De Simone, et al.
Drugs in Context|December 5, 2019
Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literaturePietro Sollena, Maria Mannino, Francesco Tassone, et al.
Skin Health and Disease|June 1, 2026
Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitorsElena Ippoliti, Niccolò Gori, Giulia Coscarella, et al.
Patient Preference and Adherence|November 26, 2021
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in ItalyGiuseppe Argenziano, Paolo Amerio, Maria Grazia Aragone, et al.
The Journal of Dermatological Treatment|October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter studyAnnunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Molecular Diagnosis & Therapy|January 29, 2017
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort StudyMarina Talamonti, Marco Galluzzo, Arianna Zangrilli, et al.
Pageof 51